Report from the Catalan Agency for Health Technology Assessment (CAHTA). Review of the scientific evidence of the clinical and economic implications of resistance of enterococcus to vancomycin.
D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D016983:Enterococcus; D019317:Evidence-Based Medicine; D016908:Gram-Positive Bacterial Infections / Q000191:economics / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D017053:Infection Control; D011159:Population Surveillance; D015995:Prevalence; D012307:Risk Factors; D013030:Spain / Q000453:epidemiology; D013673:Technology Assessment, Biomedical / Q000458:organization & administration*; D014640:Vancomycin / Q000009:adverse effects*; D020713:Vancomycin Resistance
D000900:Anti-Bacterial Agents; D014640:Vancomycin